About Qrativ
Qrativ is a company based in Cambridge (United States) founded in 2017 by Murali Aravamudan and Andrew Badley. Qrativ has raised $8.3 million across 1 funding round from investors including Matrix. Qrativ operates in a competitive market with competitors including Causaly, ScienceIO, Collaborative Drug Discovery, BioSymetrics and Citelighter, among others.
- Headquarter Cambridge, United States
- Founders Murali Aravamudan, Andrew Badley
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.3 M (USD)
in 1 rounds
-
Latest Funding Round
$8.3 M (USD), Series A
Jul 14, 2017
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Qrativ
Qrativ has successfully raised a total of $8.3M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.3 million completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Qrativ
Qrativ has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Matrix.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage ventures are funded by the investment firm.
|
Locked | Locked | Locked |
Investor details for Qrativ
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Qrativ
Investment portfolio details for Qrativ
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Qrativ
Detailed financials for Qrativ
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Qrativ Comparisons
Peer comparison for Qrativ
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Qrativ
Qrativ operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Causaly, ScienceIO, Collaborative Drug Discovery, BioSymetrics and Citelighter, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based data-mining tools for scientific evidence discovery are provided.
|
|
| Locked | Locked | Locked |
Provider of AI solutions transforming medical text into enriched healthcare data
|
|
| Locked | Locked | Locked |
Biological and chemical data are managed securely in a database.
|
|
| Locked | Locked | Locked |
Provider of a cognitive computing-based biomedical intelligence platform
|
|
| Locked | Locked | Locked |
Digital writing solution for K-20 students
|
Detailed competitors of Qrativ
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Qrativ
Complete news archive for Qrativ
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Qrativ
Qrativ was founded in 2017.
Qrativ is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Murali Aravamudan is the current CEO of Qrativ. They have also founded this company.
Qrativ is a funded company, having raised a total of $8.3M across 1 funding round to date.
Qrative is a joint venture formed by Mayo Clinic nference to identify treatments for rare diseases using drug purposing approach. The company has developed a propriety drug purposing platform, Darwin.ai, leverages proprietary data from Mayo Clinics (EHRs, prescription diagnosis data, patient-treatment omics) and nferences knowledge synthesis AI platform (data extracted from PubMed, Clinical Trials, etc). The company claims that the drug developers can use its platform to identify uses for their molecules at an early phase of development. The company has got 8.3 million funding from Matrix Capital Management, Matrix Partners, and the Mayo Clinic.
Qrativ's top competitors include Causaly, ScienceIO and BioSymetrics.
Qrativ has 1 investor. Key investors include Matrix.